Development of new monoclonal antibodies against signal transducer and transcription activator "stati" protein and its endogenous inhibitor "socs3" protein. Construction of kit for detection of hla-g antigens.
Development of the use of tumour necrosis factor related apoptosis inducing ligand or apo2 ligand (trail) as an efficient anti-tumour therapy as an alternative to chemo/radiotherapy.
Development of apple cultivars with resistance to diseases and better fruit quality by combining traditional methods of apple breeding with the most recent selection technologies using molecular tools.
Using well-characterized antibodies to form the basis for the development of diagnostic kits to monitor neurodegenrative processes.
Development and pre-clinical testing of at least two compounds for the effective treatment of migraines.
Development of a direct and effective method of directly imaging the structural degradation of peripheral neurones as encountered in various types of neuropathies.
Efficient control strategies against phytoplasma vectoring psyllids will be established by the help of molecular markers to study their life cycle, by determining the transmission parameters and by developing disturbation strategies.
Production of antibodies against novel gene products(proteins) is essential, but there are often obstacles to studying brain function or disease. Commercial availability of sets of antibodies will be useful to many brain research facilities.
To develop, manufacture, test and introduce to the market a completely new type of medical device for vacuum therapy.
To select efficient symbiotic soil fungi for production of blueberries,raspberries&mulberries in arid ecosystems.The outcome will be novel mycorrhizal inocula tuned to increase stress tolerance of plants&reduce the input of agrochemicals.